Dr. Jeffrey's current research and scholarly interests include pancreatic MDCT, thyroid ultrasound/biopsy, virtual colonoscopy, imaging of appendicitis, and hepatic MDCT.

Dr. Longo's research group is focused on the discovery of cellular signaling mechanisms that serve as a basis for the development of novel therapeutic approaches for Alzheimer's disease, Huntington's disease and other neurological disorders.

Dr. Palumbi's research interests are widespread, and he has published on the genetics and evolution of sea urchins, whales, cone snails, corals, sharks, spiders, shrimps, bryozoans, and butterflyfishes.

Dr. James Zehnder is the director of the coagulation laboratory, co-director of the molecular diagnosis laboratories, medical director of the anticoagulation clinic, attending physician in the thrombosis and bleeding disorders clinic, and associate director of the transfusion service.

Dr. Giaccia's research program is focused on translating basic science findings on the role of hypoxia in tumor progression and resistance to therapy to pre-clinical models of cancer that they ultimately hope to take into the clinic.

Dr. Dorigo is the Director of Stanford Obstetrics and Gynecology in the Division of Gynecologic Oncology and the Director of the Stanford Gynecologic Oncology Clinical Care Program.

Dr. Haddad's clinical focuses include heart transplantation, right heart failure, and cardiology.

Dr. West's lab research focuses on the study of human soft tissue tumors and carcinomas using ultra high-throughput sequencing, genomics, gene microarray, and tissue microarray technology.

Dr. Bendall's specialties are the study of Protein Biochemistry, Mass Spectrometry, Stem Cell Biology, and ICP-MS based flow cytometry (CyToF).

Dr. Buyyounouski's clinical focus is geared towards Bladder Cancer, Radiation Oncology, Brachytherapy, Testicular Cancer, Radiotherapy, Image-Guided, Prostate Cancer, Radiotherapy, Intensity-Modulated, Stereotactic Body Radiotherapy, and Cancer > Radiation Oncology.